Les bibliographies suivantes ne sont pas exhaustives, mais elles peuvent servir de base à une recherche plus approfondie. N'hésitez pas à communiquer avec nous pour obtenir une bibliographie plus complète sur ces sujets ou tout autre lié aux dépendances.

Tous les livres et les articles cités dans nos bibliographies sont disponibles sur place au CQDT ou peuvent être demandés par prêt entre bibliothèques.

Dossiers spéciaux antérieurs

Monographies

• Bertrand, B. (2003). Le "tourisme d'assistance" des usagers de drogues: vers l'ouverture d'une salle d'injection à moindre risque. Paris: L'Harmattan. [362.2916 B548t 2003]
• (2002) Colloque international toxicomanies, hépatites, sida 2001: Toxicomanies, hépatites, sida: dans le secret des drogues et les virus: actes du Colloque THS5, Grasse 2001. Paris: Frison-Roche. [362.29 T758 2001]
• (2004) Colloque international toxicomanies, hépatites, sida 2003: Toxicomanie, hépatites, sida: actes du colloque THS6, Aix-en-Provence 2003. Paris: Frison-Roche. [362.29 T755 2003 v.1]
• Elliott, R. (2002). Créer des lieux sécuritaires pour l'injection au Canada: questions juridiques et éthiques = Establishing safe injection facilities in Canada. [Montréal]: Réseau juridique canadien VIH-SIDA = Canadian HIV AIDS Legal Network. [614.5993 E46c 2002]
• Lines, R. (2002). Lutte au VIH/sida dans les prisons: trop peu, trop tard: un rapport d'étape = Action on HIV/AIDS in prisons: too little, too late: a report card. [Montréal]: Réseau juridique canadien VIH-SIDA. [616.9792 L754L 2002]
• Prévost, M. (2000). Sida 101. Montréal: Comité des personnes atteintes du VIH du Québec. [362.1969792 P944s 2000]

Articles

• Amil, A. (2004). Changing profiles of injecting drug users with aids in a hispanic population. Addiction, 99(9), 1147-1156.
• Bluthenthal, R.N. (2004). Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction, 99(9), 1136-1146.
• Copenhaver, M., Avants, S.K., Warburton, L.A., et al. (2003). Intervening effectively with drug abusers infected with VIH: taking into account the potential for cognitive impairment. Journal of psychoactive drugs, 35(2), 209-218.
• Des Jarlais, D. (2002). HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia. The International journal of drug policy, 13(3), 165-170.
• Dickson-Gomez, J., Weeks, M., Martinez, M., et al. (2006). Times and places: Process evaluation of a peer-led hiv prevention intervention. Substance Use & Misuse, 41(5), 669-690.
• (2006). Drug abuse and HIV/AIDS: International research lessons and imperatives. Drug and alcohol dependence, 82(Supp.1), Numéro thématique.
• Farabee, D., Prendergast, M. & Cartier, J. (2002). Methamphetamine use and HIV risk among substace-abusing offenders in California. Journal of psychoactive drugs, 34(3), 295-300.
• Haley, N., Roy, É. & Leclerc, P. (2003). Interventions de prévention efficace contre le VIH et l'hépatite C chez les jeunes utilisateurs de drogues par injection. Drogues, santé et société, 2(1), 175-207.
• Johnson, R.A. (2002). HIV risk behaviors in African-American drug injector networks: implication of injection-partner mixing and partnership characteristics. Addiction, 97(8), 1011-1024.
• Krupitsky, E.M. (2005). Alcohol use and HIV risk behaviors among HIV-infected hospitalized patients in St. Petersburg, Russia. Drug and alcohol dependence, 79(2), 251-256.
• Liebschutz, J.M. (2005). Physical and sexual violence and health care utilization in HIV-infected persons with alcohol problems. Aids care, 17(5), 566-578.
• Medrano, M.A. & Hatch, J.P. (2005). Childhood trauma, sexually transmitted diseases and the perceived risk of contracting hIV in a drug using population. American journal of drug and alcohol abuse, 31(3), 403-416.
• Miller, M. & Neaigus, A. (2002). Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users", v. 14, no 6, p. Aids care, 14(6), 801-813.
• Mizuno, Y., Purcell, D.W. & Dawson-Rose, C. (2003). Correlates of depressive symptoms among HIV-positive injection drug users: the role of social support. 15(5), 689-698.
• Noël, L., Côté, N., Godin, G., et al. (2002). Processus de marginalisation et risque pour le VIH chez les utilisateurs de drogues par injection. Psychotropes, 8(2), 7-13.
• Parsons, J.T. & Halkitis, P.N. (2002). Sexual and drug-using practices of HIV-positive men who frequent public and commercial sex environment. Aids care, 14(6), 815-826.
• Patterson, D.A., Cloud, R.N. & Mckiernan, P.M. (2004). Treating addicted HIV patients: the case for motivational interviewing. Counselor: the magazine for addiction professionals, 5(3), 33-40.
• Pollack, H. A., D'Aunno, T. & Lamar, B. (2006). Outpatient substance abuse treatment and HIV prevention: An update. Journal of subst abuse treatment, 30(1), 39-47.
• Sanchez, J. (2002). High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk reduction. Aids care, 14(3), 391-398.
• Special double issue: Sterile syringe access for injection drug users in the 21st century: progress and prospects. (2003). International journal of drug policy, 14(5-6).
• Spittal, P.M., Bruneau, J. & Craib, K.J.P. (2003). Surviving the sez trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. Aids care, 15(2), 187-195.
• Stein, M.D. (2005). Reductions in HIV risk behaviors among depressed drug injectors. American journal of drug and alcohol abuse, 31(3), 417-432.
• Strathdee, S.A. (2003). Sexual HIV transmission in the context of injection drug use: implications for interventions. International journal of drug policy, 14(1), 79-81.
• Strauss, S., Deren, S., Rindskopf, D.M., et al. (2002). (2002). "HIV-positive out-of-treatment drug users who are unaware of their HIV status: predictors of who gets tested and who returns for test results", v. 32, no 4, p. Journal of drug issues, 32(4), 1017-1032.
• Sullivan, L.E. (2005). Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction, 100(2), 150-158.
• Sullivan, L.E. & Fiellin, D.A. (2004). Hepatitis C and HIV infections: implications for clinical care in injection drug users. American journal on addictions, 13(1), 1-20.
• Theall, K.P., Sterk, C.E. & Elifson, K.W. (2003). Male condom use by type of relationship following an HIV intervention among women who use illegal drugs. Journal of drug issues, 33(1), 1-28.
• Vertefeuille, J., Strathdee, S., Huettner, S., et al. (2002). Factors associated with HIV seroprevalence among participants enrolling at a needle exchange program. Journal of drug issues, 32(4), 1125-1138.
• Vickerman, P. & Watts, C. (2002). The impact of an HIV prevention intervention for injecting drug users in Scetlogorsk, Belarus: model predictions. The International journal of drug policy, 13(3), 149-164.
• Wang, Q. & Lin, G. (2003). Sex exchange and HIV-related risk behaviors among female heroin users in China. Journal of drug issues, 33(1), 119-132.
• Witteveen, E. & Ameijden, E.J.C.V. (2002). Drug users and HIV-combination therapy (HAART): factors which impede of facilitate adherence", v. 37, no 14, p. Substance use & misuse, 37(14), 1905-1925.

Matériel d'animation

• Faire sa veine Montréal: Concertation en toxicomanie Hochelaga-Maisonneuve. (1999). [1 vidéocassette], 00:32:45. [VIH F799f 1999]
• Lahaie, C. (1996). Feu vert sur la réduction de risques [1 jeu + 1 guide]. Montréal: Centre Dollard-Cormier, [WC 144 L183 1996]

Dernière mise à jour: 7 juin 2006